Rohit Jain
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immunology and Allergy top 2%
Papers in
- Co-authors
- Wolfgang Weninger (18 shared papers)Sunil Badve (12 shared papers)Ben Roediger (9 shared papers)Rutika Mehta (11 shared papers)Maté Biro (2 shared papers)Harikrishna Nakshatri (4 shared papers)Michele A. Grimbaldeston (3 shared papers)Lai Guan Ng (3 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)Annals of Oncology (6 papers)Urologic Oncology Seminars and Original Investigations (5 papers)Clinical Genitourinary Cancer (4 papers)Modern Pathology (3 papers)
- Partner nations
- United StatesIndiaAustralia
In The Last Decade
Rohit Jain
151 papers receiving 3.8k citations
Rohit Jain's Hit Papers
Peers
Comparison fields: 5 of 129
- Immunology 1.2k
- Immunology and Allergy 238
- Oncology 843
- Dermatology 210
- Cancer Research 307
Countries citing papers authored by Rohit Jain
This map shows the geographic impact of Rohit Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Jain more than expected).
Fields of papers citing papers by Rohit Jain
This network shows the impact of papers produced by Rohit Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Jain. The network helps show where Rohit Jain may publish in the future.
Co-authors
The 25 scholars most cited alongside Rohit Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 380 | |
| 2 | TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors Hit paper breakdown → | 2021 | 365 |
| 3 | 2013 | 218 | |
| 4 | 2014 | 161 | |
| 5 | 2009 | 160 | |
| 6 | 2011 | 158 | |
| 7 | 2011 | 156 | |
| 8 | 2012 | 145 | |
| 9 | 2011 | 138 | |
| 10 | 2015 | 130 | |
| 11 | 2011 | 107 | |
| 12 | 2014 | 98 | |
| 13 | 2014 | 93 | |
| 14 | 2009 | 71 | |
| 15 | Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. | 1996 | 70 |
| 16 | 2014 | 58 | |
| 17 | 2011 | 57 | |
| 18 | 2021 | 55 | |
| 19 | 2011 | 49 | |
| 20 | TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes Hit paper breakdown → | 2024 | 45 |
About Rohit Jain
Rohit Jain is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 161 papers that have together received 3.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (59 papers), Cancer Immunotherapy and Biomarkers (38 papers), Urinary and Genital Oncology Studies (18 papers), Renal cell carcinoma treatment (17 papers), Immunotherapy and Immune Responses (14 papers), Prostate Cancer Treatment and Research (10 papers), Cancer Genomics and Diagnostics (10 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Immunology (1.2k citations), Immunology and Allergy (238 citations), Oncology (843 citations), Dermatology (210 citations) and Cancer Research (307 citations). Rohit Jain has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Wolfgang Weninger, Sunil Badve, Ben Roediger, Rutika Mehta, Maté Biro, Harikrishna Nakshatri, Michele A. Grimbaldeston, Lai Guan Ng, Andrew J. Mitchell and Philip L. Tong. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Urologic Oncology Seminars and Original Investigations, Clinical Genitourinary Cancer and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.